e-learning
resources
Monograph
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interpretation of exhaled volatile organic compounds
G. Pennazza, M. Santonico, E. Martinelli, A. D'Amico, C. Di Natale
Source:
Eur Respir Monogr 2010; 49: 115-129
Journal Issue:
Exhaled Biomarkers
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Pennazza, M. Santonico, E. Martinelli, A. D'Amico, C. Di Natale. Interpretation of exhaled volatile organic compounds. Eur Respir Monogr 2010; 49: 115-129
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
A systematic review of the diagnostic accuracy of volatile organic compounds in airway diseases and their relation to markers of type-2 inflammation
Source: ERJ Open Res, 7 (3) 00030-2021; 10.1183/23120541.00030-2021
Year: 2021
Design of accurate COPD classification model based on volatile organic compounds from exhaled air
Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future
Year: 2008
Limited clinical value of exhaled volatile organic compound measurements in childhood asthma
Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018
Year: 2018
Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Comprehensive analysis of volatile organic compounds in human breath gas samples
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003
Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
Source: Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019
Year: 2020
A new possibility of process monitoring in lung cancer: Volatile organic compounds detected with ion mobility spectrometry to follow the success of the therapeutic process
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
Exhaled volatile organic compounds as markers for medication use in asthma
Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019
Year: 2020
Combined effect of volatile organic compounds on respiratory health in adults
Source: Annual Congress 2010 - Indoor air and respiratory disease
Year: 2010
Standardization of exhaled volatile organic compounds (VOCs) measurement
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Smoking in car: Monitoring pollution of particulate matter (mass and particle number), of organic volatile compounds and of carbon monoxide. Evaluating the most suitable ETS marker, and the effect of opening the driver‘s window
Source: Annual Congress 2010 - Passive smoking
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept